Frazier

Overview

Founded in 1991 by Alan D. Frazier, Frazier Healthcare Partners is a Seattle-based private equity firm focused exclusively on the healthcare industry. The firm has raised over $11 billion in capital and invested in more than 200 healthcare companies across various sectors, including pharmaceuticals, medical devices, and healthcare services. It operates two main investment strategies: Growth Buyout and Life Sciences. With headquarters in Seattle, Washington, and an additional office in Menlo Park, California, Frazier Healthcare Partners remains a prominent player in the private equity sector, leveraging its extensive industry expertise to foster market-leading healthcare businesses.

Recent Developments

  • May 2025: Frazier Healthcare Partners announced the addition of Ben Hansen to their Center of Excellence as a partner specializing in finance and operations, enhancing their strategic capabilities in financial guidance across industries. The firm also received a strategic minority investment from Petershill at Goldman Sachs Alternatives, which reflects confidence in Frazier's investment approach.
  • November 2024: The company closed its latest flagship fund, Frazier Healthcare Growth Buyout Fund XI, L.P., raising $2.3 billion despite a challenging fundraising environment. This fund aims to acquire controlling stakes in middle-market healthcare companies.
  • September 2024: Frazier Healthcare initiated a Diversity, Equity, Inclusion, and Advancement (DEIA) Scorecard initiative to promote transparency and improvement in DEIA practices across its portfolio companies. This included workshops and coaching sessions for the management teams.

Company Information

AttributeInformation
Founding Date1991
HeadquartersSeattle, Washington
FoundersAlan D. Frazier
RevenueNot publicly available
ProfitsNot publicly available
Key InvestorsPetershill (Goldman Sachs Alternatives)
IndustryPrivate Equity
Number of EmployeesInformation not available

Early History

Frazier Healthcare Partners began its journey in 1991 when founder Alan D. Frazier envisaged a firm dedicated to healthcare investments. Initially, the firm focused on building a robust foundation in healthcare venture capital. By collaborating with emerging entrepreneurs and healthcare professionals, Frazier laid the groundwork for robust investment strategies that focus on innovation and growth in the healthcare sector. The foundation was built on identifying and nurturing promising healthcare companies to their full potential, setting a precedent for its later comprehensive private equity operations.

Company Profile and Achievements

Frazier Healthcare Partners operates with a distinctive focus on two main strategies: Growth Buyout and Life Sciences.

  • Growth Buyout: Targets healthcare services and pharmaceutical businesses, concentrating on profitable lower-middle market companies. This strategy involves buyouts and providing capital to expand business operations.
  • Life Sciences: Invests in therapeutics and innovations addressing unmet medical needs.
    • Major Investments: Includes Array BioPharma and Cadence Pharmaceuticals.
  • Milestones:
    • Closed Frazier Healthcare Growth Buyout Fund X at $1.4 billion in 2021.
    • Raised $987 million for Frazier Life Sciences XI in 2022.

Current Operations and Market Position

Frazier Healthcare Partners is recognized for its robust approach to healthcare investments. By harnessing over 30 years of industry knowledge, the firm continues to develop and implement successful, theme-driven investment strategies. The firm maintains a competitive edge through its ability to adapt and identify emerging trends in healthcare, supporting businesses with substantial potential for growth and innovation.

Conclusion

Frazier Healthcare Partners maintains a significant foothold in the private equity landscape, with a dedicated focus on the healthcare sector. Their strategy of aligning with emerging trends and fostering strategic partnerships with proven executives positions them well for future growth and influence. As the company continues to innovate and adapt to changing market dynamics, it is poised to maintain its status as a leader in the healthcare investment domain, impacting the industry through strategic investments and successful partnerships.

References

  1. Frazier Healthcare Partners - Official Website
  2. BusinessWire - Frazier Healthcare Growth Buyout Fund XI
  3. Frazier Healthcare Partners LinkedIn
  4. BusinessWire - Goldman Sachs Alternatives Investment
  5. UNPRI - Frazier Healthcare DEIA Initiative